Ranbezolid
![]() | |
Clinical data | |
---|---|
Other names | RBX-7644 |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H24FN5O6 |
Molar mass | 461.450 g·mol−1 |
3D model (JSmol) | |
| |
|
Ranbezolid (RBx7644) is an oxazolidinone antibacterial. It competitively inhibits monoamine oxidase-A (MAO-A).[1]
References
[edit]- ^ Naruganahalli KS, Shirumalla RK, Bansal V, Gupta JB, Das B, Ray A (September 2006). "Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats". European Journal of Pharmacology. 545 (2–3): 167–72. doi:10.1016/j.ejphar.2006.06.065. PMID 16899241.